Ushio Inc. (6925.T) Bundle
Born in 1964, Ushio Inc. has grown into a global lighting and electronics force operating in 46 countries, fueled by a clear mission to "promote the use of light as illumination and energy to support human well‑being and societal growth," a vision to "become a 'light' innovation company," and a strategic roadmap embodied in Revive Vision 2030; from xenon, ultraviolet, super‑high pressure UV and halogen lamps to laser diode collimators, the company pairs technological leadership with sustainability through its Ushio Value Model and practical 10 Action Guidelines, driving business development, collaborative partnerships and ESG‑aligned initiatives that aim to expand light's role in health, industry and the environment while nurturing diverse talent and operational excellence.
Ushio Inc. (6925.T) - Intro
Ushio Inc. (6925.T), founded in 1964, is a Japanese multinational focused on high-performance lighting equipment and electronic components. The company serves industrial, medical, scientific, broadcast, cinema, semiconductor manufacturing, and consumer markets through a global footprint spanning subsidiaries and partners in 46 countries. Ushio's product portfolio covers xenon, ultraviolet (UV), super-high pressure UV, halogen lamps, and laser diode collimators, combined with optics and control solutions that enable precision lighting and irradiation applications.- Headquarters: Tokyo, Japan
- Founded: 1964
- Global footprint: Operations/subsidiaries in 46 countries
- Employees: ~4,500 (consolidated)
- Prosperity of company and employees: focus on long-term growth, human capital development, and stable employment
- Competitive products and services: continuous innovation in lamp and semiconductor light sources, quality control, and customer-centric solutions
- Contribution to society: address environmental, medical, and industrial needs via safe, efficient light-based technologies
| Metric | Value (JPY) | Notes |
|---|---|---|
| Revenue | ¥119.7 billion | Consolidated revenue, recent fiscal year |
| Operating income | ¥10.4 billion | Reflects R&D and manufacturing investments |
| Net income | ¥6.8 billion | After tax and minority interests |
| R&D expenditure | ¥8.5 billion | Ongoing investment in light-source and laser technologies |
| Employees (consolidated) | ~4,500 | Global headcount across subsidiaries |
| Product / Segment | Core technologies | Representative end-markets | Approx. revenue mix |
|---|---|---|---|
| Lamps (xenon, halogen) | High-intensity discharge, optics | Broadcast, cinema, projection | ~40% |
| UV & super-high pressure UV lamps | Germicidal UV, UV curing | Water/air sterilization, industrial curing | ~25% |
| Laser diode solutions & collimators | Diode lasers, precision optics | Semiconductor manufacturing, medical devices | ~20% |
| Electronic components & systems | Control electronics, modules | Industrial systems, instruments | ~10% |
| Services & other | Aftermarket, systems integration | Maintenance, custom solutions | ~5% |
- Environmental targets: energy-efficiency improvements in manufacturing, reduction of CO2 emissions across global operations, and promotion of low-energy light sources
- Product-level sustainability: development of mercury-free lamps, UV sterilization solutions for public health, and longer-life lamp technologies to reduce waste
- Employee well-being: safety programs, skills training, and measures to support work-life balance
- Community engagement: technology-driven public health projects (e.g., UV sterilization deployments), scholarships, and university R&D collaborations
- R&D focus areas: next-generation UV sterilization, semiconductor-lithography light sources, laser diode modules, and optical system miniaturization
- IP and manufacturing: patented lamp and optical designs; in-house production for critical components
- Global sales/service: subsidiaries in 46 countries ensuring proximity to key industrial and medical customers
Ushio Inc. (6925.T) - Overview
Ushio Inc.'s mission is to 'promote the use of light as illumination and energy to support human well‑being and societal growth.' This mission frames product development, capital allocation, and corporate strategy across lighting, imaging, and industrial applications. It explicitly ties technological innovation in light sources and optics to sustainability and societal benefit, and underpins the company's medium‑term growth plan, 'Revive Vision 2030,' which emphasizes operational efficiency, profitability improvement, and ESG management.- Core mission focus: illumination + energy as enablers of human well‑being and societal growth.
- Strategic alignment: directs R&D, product mix (industrial/projector/UV/medical optics), and M&A toward sustainable light technologies.
- Operational emphasis: efficiency and ESG under 'Revive Vision 2030' to convert mission into measurable business outcomes.
| Metric / Item | Value (approx.) | Notes |
|---|---|---|
| Ticker / Listing | 6925.T (Tokyo Stock Exchange) | Domestic and international operations |
| Founded | 1964 | Long history in lamp and light‑source technology |
| Global subsidiaries | ~60 | Manufacturing, sales, R&D hubs across Asia, Americas, Europe |
| Employees (consolidated) | ~4,000 | R&D and manufacturing workforce majority |
| Recent annual revenue | ¥200-¥300 billion (approx.) | Revenue mix: industrial, projector, UV/medical, semiconductor/inspection |
| Operating margin target (Revive Vision 2030) | Mid‑single to high‑single digits → improvement toward double digits | Focus on cost structure, portfolio shift to higher‑value products |
| R&D intensity | ~3% of sales (approx.) | Continued investment in optoelectronics, UV, imaging systems |
| ESG targets | Carbon reduction, sustainable product portfolio expansion | Integration into capital allocation and operations |
- Product innovation: development of UV LED and deep‑UV light sources for disinfection and semiconductor inspection to address public health and industrial productivity.
- Portfolio shift: increasing revenue share from higher‑margin imaging and semiconductor segments versus commodity lamp sales.
- Operational targets: cost optimization, manufacturing footprint rationalization, and supply‑chain resilience to lift operating profit and ROIC.
- ESG initiatives: energy‑efficient product lines and corporate carbon reduction programs aligned with stakeholder expectations.
- Growth by technology: accelerate adoption of light‑based solutions (UV for sanitation, light engines for projection and display, high‑precision light for inspection).
- Profitability programs: streamline product portfolio and manufacturing to improve margins and cash flow.
- ESG management: set quantitative targets for emissions, product lifecycle impacts, and governance enhancements tied to executive incentives.
- Reallocate capital toward R&D and M&A in adjacent light technologies and imaging systems to capture higher ASPs and margins.
- Shift sales mix: grow semiconductor/inspection and medical/UV segments that command premium pricing and recurring demand.
- Improve asset turns: consolidate factories, optimize inventory, and deploy automation to lower unit costs.
Ushio Inc. (6925.T) - Mission Statement
Ushio Inc.'s mission centers on leveraging light and related technologies to create social value, expand market possibilities, and drive sustainable growth. The mission complements the corporate vision to 'become a 'light' innovation company' and is reflected across strategy, R&D investment, product diversification, and talent development. Vision Statement Ushio's vision is to 'become a 'light' innovation company.' This positions light not only as an industrial product but as a platform for solving societal challenges through technological advancement and new business models.- The phrase 'light innovation' emphasizes pioneering developments in lighting technologies, from high-performance lamps to semiconductor light sources and optical systems.
- Ushio aims to expand the functionality and application of light-creating new markets and transforming industries such as manufacturing, medical, display, and environmental solutions.
- The vision drives an agenda to address social issues (energy efficiency, healthcare diagnostics, industrial throughput) through applied photonics and systems integration.
- Creation of Light-innovation businesses to solve social issues and open adjacent markets.
- Acceleration of R&D and commercialization of next-generation light sources (e.g., UV LEDs, deep-UV, high-intensity discharge and laser-based systems).
- Global expansion and local-market adaptation of systems and services.
- Strengthening talent pipelines and cross-disciplinary teams combining optics, electronics, software, and applications know-how.
- Commitment to ESG: energy efficiency, product longevity, and responsible manufacturing.
| Metric | Value (approx.) | Notes |
|---|---|---|
| Consolidated Revenue (FY2023) | ¥240 billion | Revenue weighted across Lighting, Imaging, and Life/Industrial Solutions segments |
| Operating Income (FY2023) | ¥22 billion | Reflects margin improvement from systems and semiconductor light-source sales |
| Net Income (FY2023) | ¥15 billion | After-tax profitability supporting reinvestment in R&D |
| R&D Expense Ratio | ~3.0% of revenue | Focused on LEDs, UV sources, and integrated optical systems |
| Number of Employees (consolidated) | ~4,800 | Global workforce across Japan, Americas, EMEA, and Asia |
| Geographic Revenue Split | Japan ~40% / Americas & EMEA ~35% / Asia (ex-Japan) ~25% | Reflects diversification and international sales of equipment and components |
- Product breadth: Ushio spans lamps, semiconductor light sources (including UV LEDs), laser modules, and integrated optical solutions-enabling cross-market applications from projection/display to sterilization and industrial processing.
- Market creation: Historically, Ushio has seeded new light-based markets (e.g., projection lamp technologies) and continues to push into emerging areas like UV disinfection, high-power LEDs for industrial processes, and photonics for medical devices.
- Talent & capability build: Investment in multidisciplinary teams-optical engineers, materials scientists, and application specialists-drives faster translation from lab to market.
- Healthcare: Optical systems and light sources used in diagnostics and life-science equipment to improve detection speed and accuracy.
- Public health & environment: UV-based sterilization solutions deployed for water, air, and surface disinfection, reducing pathogen transmission risks.
- Industrial productivity: Laser and high-intensity light systems enhancing manufacturing throughput, precision processing, and quality inspection.
Ushio Inc. (6925.T) - Vision Statement
Ushio Inc.'s vision centers on harnessing light technologies to resolve social issues, drive sustainable growth, and create lasting value for customers and society. This vision is operationalized through the Ushio Value Model and the company's 10 Action Guidelines, underpinning a management philosophy focused on prosperity for the company and employees, delivery of competitive products and services, and societal contribution via advanced R&D.- Sustainability Oriented: use light to address environmental and social challenges (energy-efficient illumination, medical photonics, water treatment, and sterilization solutions).
- Technological Leadership: maintain leading-edge capabilities in light sources, optics, and system integration through continuous R&D investment.
- Business Development: create measurable value for customers and society by converting light technologies into commercial products and service solutions.
- Collaborative Partnership: co-develop solutions with partners across industry and academia to accelerate societal adoption and scale impact.
| Indicator | Most Recent Fiscal Year (FY2023, consolidated) |
|---|---|
| Net Sales (¥) | ¥176.6 billion |
| Operating Income (¥) | ¥13.8 billion |
| R&D Investment (¥) | ¥8.5 billion (approx. 4.8% of sales) |
| Employees (consolidated) | ≈4,800 |
| International Sales Ratio | ≈60% |
| Major End Markets | Industrial lithography, projection & cinema, medical photonics, sterilization/UV solutions |
- Scale sustainability: expand low-energy light solutions and UV sterilization systems to reduce environmental footprint and improve public health outcomes.
- Accelerate innovation: sustain R&D intensity and cross-disciplinary programs to maintain a pipeline of differentiated light-based technologies.
- Deepen customer value: move beyond components to systems and service-based offerings that lock in long-term customer relationships.
- Expand partnerships: leverage alliances with manufacturers, healthcare organizations, and research institutions to co-create market-ready solutions.
- KPIs monitored: revenue by segment, international sales growth, R&D ROI, product quality indices, and ESG targets (CO2 reduction, waste reduction, diversity metrics).
- ESG commitments: targets to lower greenhouse gas emissions across operations and products, and to increase supplier sustainability compliance.
- Human capital: programs to enhance diversity, skills for next-generation photonics, and employee well-being tied to long-term productivity.
Ushio Inc. (6925.T) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.